The government-funded venture capital firm TMF Management Co (TMF管顧公司) yesterday said it is talking to several public and private investors to raise as much as NT$5 billion (US$172.89 million) by December, with the aim of putting Taiwan on the global biotech map.
The fund, called Taiwan Medtech Fund (TMF), got an injection of NT$1 billion from the Executive Yuan’s National Development Fund in June.
State-run firms including CPC Corp, Taiwan (台灣中油), China Steel Corp (中鋼), Taiwan Sugar Corp (台糖) and Taiwan Salt Co (台鹽) are involved in the talks and their combined investments will be not exceed NT$1 billion, TMF Management chairman Jang Yue-teh (張有德) said.
“We are also looking to private firms for capital,” he told reporters, adding that investor targets include entrepreneurs who have passion for medical health, especially those who have experience in the field or who had family members that have suffered from serious illnesses.
Hon Hai Group (鴻海集團) chairman Terry Gou’s (郭台銘) younger brother died of bone marrow cancer, while Quanta Computer Inc (廣達) chairman Barry Lam (林百里) has battled lung cancer.
When asked if firms such as Hon Hai were on the target list, Jang declined to comment, but said there would be more announcements soon.
“Taiwan has been talking about developing its biotech sector for more than 20 years,” he said. “But progress is going nowhere given a lack of talent, capital and an understanding of its importance.”
The venture capitalist plans to set up incubation centers that will generate, develop and -commercialize new ideas, and help market the end products in China, where the huge market could lead to big sales possibilities, said Stan Shih (施振榮), chairman of iD SoftCapital Inc (智融集團) and the founder of Acer Group (宏碁集團).
iD SoftCapital was invited by TMF Management to share its experiences and the former has not ruled out the possibility of investing in some projects.
The incubation centers would generate ideas mainly through research institutes and from academics, although they may come from anywhere in the world, as long as the ideas benefit Taiwan in certain ways, Jang said.
He said viable projects would either need to have their products produced here, or include -Taiwanese research and development teams, or Taiwan would have to have a say in the commercialization of the product, he said.
TMF is looking to invest in projects that research illnesses such as diabetes, sleeping disorders, cardiovascular disease and in fields including neurosciences and orthopedics, as well as remote and home-care medical services.
Jang is a partner in the US-based Vertical Group, a venture capital firm focused on medical technology and biotechnology.
He has more than 20 years of experience in various executive positions in the healthcare industry and currently serves on the boards of directors of Dynamic Implants, Forte Bio Inc and Inphenix Corp.
Prior to the Vertical Group, he was president and CEO of Embol-X, a private company engaged in the development of proprietary medical devices to prevent strokes during cardiac surgery.
Hon Hai Precision Industry Co (鴻海精密) yesterday said that its research institute has launched its first advanced artificial intelligence (AI) large language model (LLM) using traditional Chinese, with technology assistance from Nvidia Corp. Hon Hai, also known as Foxconn Technology Group (富士康科技集團), said the LLM, FoxBrain, is expected to improve its data analysis capabilities for smart manufacturing, and electric vehicle and smart city development. An LLM is a type of AI trained on vast amounts of text data and uses deep learning techniques, particularly neural networks, to process and generate language. They are essential for building and improving AI-powered servers. Nvidia provided assistance
GREAT SUCCESS: Republican Senator Todd Young expressed surprise at Trump’s comments and said he expects the administration to keep the program running US lawmakers who helped secure billions of dollars in subsidies for domestic semiconductor manufacturing rejected US President Donald Trump’s call to revoke the 2022 CHIPS and Science Act, signaling that any repeal effort in the US Congress would fall short. US Senate Minority Leader Chuck Schumer, who negotiated the law, on Wednesday said that Trump’s demand would fail, while a top Republican proponent, US Senator Todd Young, expressed surprise at the president’s comments and said he expects the administration to keep the program running. The CHIPS Act is “essential for America leading the world in tech, leading the world in AI [artificial
DOMESTIC SUPPLY: The probe comes as Donald Trump has called for the repeal of the US$52.7 billion CHIPS and Science Act, which the US Congress passed in 2022 The Office of the US Trade Representative is to hold a hearing tomorrow into older Chinese-made “legacy” semiconductors that could heap more US tariffs on chips from China that power everyday goods from cars to washing machines to telecoms equipment. The probe, which began during former US president Joe Biden’s tenure in December last year, aims to protect US and other semiconductor producers from China’s massive state-driven buildup of domestic chip supply. A 50 percent US tariff on Chinese semiconductors began on Jan. 1. Legacy chips use older manufacturing processes introduced more than a decade ago and are often far simpler than
Gasoline and diesel prices this week are to decrease NT$0.5 and NT$1 per liter respectively as international crude prices continued to fall last week, CPC Corp, Taiwan (CPC, 台灣中油) and Formosa Petrochemical Corp (台塑石化) said yesterday. Effective today, gasoline prices at CPC and Formosa stations are to decrease to NT$29.2, NT$30.7 and NT$32.7 per liter for 92, 95 and 98-octane unleaded gasoline respectively, while premium diesel is to cost NT$27.9 per liter at CPC stations and NT$27.7 at Formosa pumps, the companies said in separate statements. Global crude oil prices dropped last week after the eight OPEC+ members said they would
RSS